Search results for "Hepatocellular carcinoma"
Aspirin use is associated with reduced risk for hepatocellular carcinoma
The findings of a recent meta-analysis provide support for an association between aspirin use and reduced risk for hepatocellular carcinoma but do not warrant use of aspirin as prophylaxis, and more research is needed, an ACP Journal Club commentary said.
https://gastroenterology.acponline.org/archives/2022/07/22/8.htm
22 Jul 2022
MKSAP Quiz: Hepatocellular carcinoma surveillance after HCV treatment
This month's quiz asks readers to determine the most appropriate biannual surveillance modality for a 62-year-old patient with compensated cirrhosis who was treated for hepatitis C virus (HCV) infection six months ago.
https://gastroenterology.acponline.org/archives/2021/10/22/4.htm
22 Oct 2021
Serum ferritin values may improve risk stratification of MASLD patients
Baseline hyperferritinemia occurred in almost one-third of study patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and was associated with higher stages of fibrosis.
https://gastroenterology.acponline.org/archives/2024/01/26/3.htm
26 Jan 2024
Lipophilic statins associated with significantly reduced hepatocellular carcinoma incidence, mortality in hepatitis
Potential benefits of lipophilic statins appeared to be dose- and duration-dependent, with the greatest reduction in hepatocellular carcinoma risk seen with use of a moderate-dose statin for about two years, according to data from a registry of Swedish patients with hepatitis B or C.
https://gastroenterology.acponline.org/archives/2019/08/23/7.htm
23 Aug 2019
Statins associated with reduced mortality risk in hepatocellular carcinoma
Inverse associations between postdiagnosis statin use and cancer-specific and all-cause mortality were consistent for low- and high-dose statins and for a range of time periods after cancer diagnosis.
https://gastroenterology.acponline.org/archives/2019/01/25/2.htm
25 Jan 2019
Regorafenib now FDA-approved to treat hepatocellular carcinoma
Approved use of the drug has been expanded to include treatment of patients with hepatocellular carcinoma who have been treated with sorafenib.
https://gastroenterology.acponline.org/archives/2017/05/26/7.htm
26 May 2017
Case series describes pouchitis after immune checkpoint inhibitors
Two unusual cases of pouchitis occurred in older men receiving therapy for esophageal squamous cell carcinoma and hepatocellular carcinoma.
https://gastroenterology.acponline.org/archives/2023/08/25/11.htm
25 Aug 2023
Clinical practice update offers recommendations on noninvasive testing for NAFLD
Noninvasive tests have the potential to significantly enhance the care of patients with nonalcoholic fatty liver disease (NAFLD) by improving detection of advanced fibrosis, according to the American Gastroenterological Association.
https://gastroenterology.acponline.org/archives/2023/08/25/1.htm
25 Aug 2023
Case reports published on gastroenterology, hepatology topics
Reports on hepatocellular carcinoma at initial cirrhosis diagnosis, asymptomatic celiac disease, and massive splenomegaly were published in the past month.
https://gastroenterology.acponline.org/archives/2023/02/24/12.htm
24 Feb 2023
U.S. sees decrease in HCC disease burden
Incidence of hepatocellular carcinoma (HCC) decreased sharply by 2.3% annually after 2011, while incidence-based mortality saw a 3.2% annual decrease after 2013, according to a study based on national data.
https://gastroenterology.acponline.org/archives/2022/02/25/2.htm
25 Feb 2022